plerixafor has been researched along with Laryngeal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Fan, GK; Guo, Y; Wang, M; Wu, C; Zheng, W | 1 |
1 other study(ies) available for plerixafor and Laryngeal Neoplasms
| Article | Year |
|---|---|
The primary growth of laryngeal squamous cell carcinoma cells in vitro is effectively supported by paired cancer-associated fibroblasts alone.
Topics: Apoptosis; Benzylamines; Cancer-Associated Fibroblasts; Carcinoma, Squamous Cell; Cell Proliferation; Chemokine CCL7; Chemokine CXCL12; Cyclams; Fibroblast Growth Factor 1; Flow Cytometry; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Heterocyclic Compounds; Humans; Laryngeal Neoplasms; Male; Neoplasm Staging; Receptors, CXCR4 | 2017 |